Ingalls & Snyder LLC grew its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 6.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,209 shares of the pharmacy operator’s stock after buying an additional 950 shares during the quarter. Ingalls & Snyder LLC’s holdings in Walgreens Boots Alliance were worth $1,269,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in WBA. Waldron LP boosted its holdings in shares of Walgreens Boots Alliance by 67.7% in the first quarter. Waldron LP now owns 4,500 shares of the pharmacy operator’s stock worth $373,000 after buying an additional 1,816 shares during the period. Russell Investments Group Ltd. boosted its holdings in shares of Walgreens Boots Alliance by 72.9% in the first quarter. Russell Investments Group Ltd. now owns 482,962 shares of the pharmacy operator’s stock worth $40,115,000 after buying an additional 203,635 shares during the period. Financial Architects Inc boosted its holdings in shares of Walgreens Boots Alliance by 299.0% in the first quarter. Financial Architects Inc now owns 3,643 shares of the pharmacy operator’s stock worth $303,000 after buying an additional 2,730 shares during the period. IFP Advisors Inc boosted its holdings in shares of Walgreens Boots Alliance by 28.9% in the first quarter. IFP Advisors Inc now owns 82,458 shares of the pharmacy operator’s stock worth $6,848,000 after buying an additional 18,478 shares during the period. Finally, Taylor Cottrill Erickson & Associates Inc. boosted its holdings in shares of Walgreens Boots Alliance by 20.9% in the first quarter. Taylor Cottrill Erickson & Associates Inc. now owns 3,507 shares of the pharmacy operator’s stock worth $291,000 after buying an additional 607 shares during the period. Institutional investors own 60.16% of the company’s stock.

Several research analysts have commented on the stock. Needham & Company LLC assumed coverage on shares of Walgreens Boots Alliance in a report on Tuesday, June 27th. They issued a “hold” rating for the company. BidaskClub cut shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Saturday, June 24th. Leerink Swann set a $86.00 target price on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Friday, July 7th. Credit Suisse Group reissued a “buy” rating and issued a $97.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, July 13th. Finally, Jefferies Group LLC reissued a “buy” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Wednesday. Two research analysts have rated the stock with a sell rating, three have given a hold rating and fifteen have issued a buy rating to the stock. Walgreens Boots Alliance has a consensus rating of “Buy” and a consensus target price of $92.06.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total transaction of $218,305.44. Following the completion of the transaction, the director now owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 78.41 on Friday. The company has a market cap of $83.91 billion, a price-to-earnings ratio of 19.80 and a beta of 1.26. Walgreens Boots Alliance, Inc. has a 12 month low of $75.18 and a 12 month high of $89.69. The company’s 50-day moving average is $81.36 and its 200 day moving average is $81.86.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping analysts’ consensus estimates of $1.30 by $0.03. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The firm had revenue of $30.12 billion during the quarter, compared to the consensus estimate of $29.72 billion. During the same quarter in the prior year, the firm posted $1.18 EPS. The business’s revenue was up 2.1% on a year-over-year basis. Equities analysts forecast that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current fiscal year.

Walgreens Boots Alliance declared that its board has authorized a share repurchase program on Thursday, June 29th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the pharmacy operator to buy up to 5.9% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th were given a dividend of $0.40 per share. The ex-dividend date was Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a yield of 2.04%. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio is 40.30%.

COPYRIGHT VIOLATION NOTICE: “Walgreens Boots Alliance, Inc. (WBA) Holdings Lifted by Ingalls & Snyder LLC” was posted by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-holdings-lifted-by-ingalls-snyder-llc/1583955.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.